Ischemic tolerance in stroke treatment

Expert Review of Cardiovascular Therapy

Volumn 7, Issue 10, 2009, Pages 1255-1261

  Sandu, Nora ^b   Cornelius, Jan ^a   Filis, Andreas ^c   Arasho, Belachew ^a,d   Perez Pinzon, Miguel ^e   Schaller, Bernhard ^a  

^a University of Paris   (France)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d ADDIS ABABA UNIVERSITY   (Ethiopia)

^e UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Ischemic tolerance; Neuroprotection; Stroke; Transient ischemic attack; Treatment

Indexed keywords

HEAT SHOCK PROTEIN 70; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KU ANTIGEN; PROTEIN P53; PROTEIN P73; RESVERATROL; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXO; VOLTAGE GATED POTASSIUM CHANNEL;

ACUTE HEART INFARCTION; BLOOD CLOT LYSIS; BRAIN INFARCTION; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DRUG MECHANISM; ELECTROACUPUNCTURE; EXCITOTOXICITY; GENE EXPRESSION REGULATION; GENOMICS; HUMAN; INDUCED HYPOTHERMIA; ISCHEMIC PRECONDITIONING; ISCHEMIC TOLERANCE; NERVOUS SYSTEM PARAMETERS; NEUROPATHOLOGY; NEUROPROTECTION; REGULATORY DNA SEQUENCE; REPERFUSION INJURY; REVIEW; STROKE; TRANSIENT ISCHEMIC ATTACK;

ANIMALS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; NEUROPROTECTIVE AGENTS; STROKE; THROMBOLYTIC THERAPY;

EID: 70449724798     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.90     Document Type: Review

References (46)

1. Cornelius JF, Sandu N, Perez-Pinzon MA, Schaller B. Treatment of acute ischemic stroke: role of ischemic tolerance in intravenous and endovascular therapies. Expert Rev. Cardiovasc. Ther. 7(4), 331-332 (2009).
2. Yenari M, Kitagawa K, Lyden P, Perez- Pinzon M. Metabolic downregulation. Stroke 2910-2917 (2008).
3. Heiss WD, Thiel A, Grond M, et al. Which targets are relevant for therapy of acute ischemic stroke? Stroke 30, 1486-1489 (1999). (Pubitemid 29296081)
4. Schaller BJ, Buchfelder M. Neuroprotection in primary brain tumors: sense or nonsense? Expert Rev. Neurother. 6(5), 723-730 (2006). (Pubitemid 43961876)
5. Schaller B. Strategies for molecular imaging dementia and neurodegenerative diseases. Neuropsychiatr. Dis. Treat. 4, 585-612 (2008). • Describes the physiology and pathophysiology of coupling of cerebral blood flow and metabolism and its implications for state-of-the-art imaging. An excellent overview about a very complex topic.
6. Schaller B, Graf R. Cerebral ischemic preconditioning: an experimental phenomenon or clinical important entity of stroke prevention? J. Neurol. 11, 1503-1511 (2002). • Although the paper is already several years old, it gives an excellent overview of the experimental phenomenon of ischemic tolerance. A must for younger colleagues.
7. Dirnagl U, Simon RP, Hallenbeck JM. Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248-254 (2003).
8. Schaller B, Graf R, Jacobs AH. Ischemic tolerance: a window to endogenous neuroprotection? Lancet 362, 1007-1008 (2003).
9. Schaller B, Graf R. Hypothermia and stroke: the pathophysiological background. Pathophysiology 10, 7-35 (2003).
10. Moncayo J, deFreitas GR, Bogousslavsky J et al. Do transient ischemic attacks have a neuroprotective effect? Neurology 54, 2089-2094 (2000). • Large series testing the hypothesis that transient ischemic attacks induce subsequent ischemic tolerance from the famous Lausanne Stroke Registry.
11. Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc. Natl Acad. Sci. USA 98, 4687-4692(2001).
12. Schaller B. Ischemic preconditioning as induction of ischemic tolerance after transient ischemic attacks in human brain: its clinical relevance. Neurosci. Lett. 377, 296-1211 (2005). • Small but fine work on transient ischemic attacks and ischemic tolerance.
13. Bickler PE, Donohoe PH, Buck LT. Molecular adaptations for survival during anoxia: lessons from lower vertebrates. Neuroscientist 8, 234-242 (2002).
14. Prass K, Ruscher K, Kursch M et al. Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22, 520-525 (2002). (Pubitemid 34477773)
15. Kapinya KJ, Lowl D, Futterer C et al. Tolerance against ischemic neuronal injury can be induced by volatile anaesthetics and is inducible NO synthase dependent. Stroke 33, 1889- 1898 (2002).
16. Shimizu K, Lacza Z, Rajapakse N et al. MitoKATP opener, diazoxide, reduces neuronal damage after middle cerebral artery occlusion in the rat. Am. J. Physiol. Heart Circ. Physiol. 283, H1005-H1011 (2002).
17. Dave KR, Sauzl I, Prado R et al. Remote organ ischemic preconditioning protect brain from ischemic damage following asphyxia cardiac arrest. Neurosci. Lett. 404, 170-175 (2006). (Pubitemid 44041791)
18. Fisher M, Ratan R. New perspectives on developing acute stroke therapy. Ann. Neurol. 53, 10-20 (2003). (Pubitemid 36083824)
19. DeGracia DJ, Kumar R, Owen CR et al. Molecular pathways of protein synthesis inhibition during brain reperfusion. J. Cereb. Blood Flow Metab. 22, 393-403 (2002).
20. Yenari MA, Fink SL, Sun GH et al. Gene therapy with Hsp72 is neuroprotective in rat models of stroke and epilepsy. Ann. Neurol. 44, 584-591 (1998). • Excellent and cornerstone work on the induction of heat-shock proteins and transient ischemic attacks.
21. Doeppner TR, Nagel F, Dietz GP et al. TAT-Hsp70-mediated neuroprotection and increased survival of neuronal precursor cells after focal cerebral ischemia in mice. J Cereb. Blood Flow Metab. 29, 1187-1196 (2009).
22. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581-1587 (1995).
23. Heiss WD, Grond M, Thiel A et al. Ischaemic brain tissue salvaged from infarction with alteplase. Lancet 349, 1599-1600 (1997). • One of the most important papers of a famous group regarding the core penumbra concept and reperfusion.
24. Schaller B. The role of endothelin in stroke: experimental data and underlying pathophysiology. Arch. Med. Sci. 2, 146-158 (2006). • There are several myths and not many facts on endothelin in stroke (and its treatment). This provides a good overview on the topic, with a strong focus on the underlying pathophysiology.
25. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136 (1986).
26. Schaller B, Cornelius JF, Sandu N et al. Oxygen-conserving reflexes of the brain: the current molecular knowledge. J. Cell. Mol. Med. 13, 644-647 (2009).
27. Ottani F, Galvani M, Ferrini D et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 91, 291-297 (1995).
28. Andreotti F, Pasceri V, Hackett DR et al. Preinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N. Engl. J. Med. 334, 7-12 (1996). (Pubitemid 26012497)
29. Dennis M, Bamford J, Sandercock P et al. Prognosis of transient ischemic attacks in the Oxfordshire Community Stroke Project. Stroke 21, 848-853 (1990). (Pubitemid 20209709)
30. Bogousslavsky J, van Melle G, Regli F. The Lausanne Stroke Registry: ana lysis of (1000) consecutive patients with first stroke. Stroke 19, 1083-1092 (1988). (Pubitemid 18227377)
31. Hakim AM. Could transient ischemic attacks have a cerebroprotective role? Stroke 25, 715-716 (1994).
32. Castillo J, Moro MA, Blanco M et al. The release of tumor necrosis factor-a is associated with ischemic tolerance in human stroke. Ann. Neurol. 54, 811-819 (2003). (Pubitemid 37498964)
33. Wegener S, Gottschalk B, Jovanovic V et al. Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 35, 616-621 (2004). • Although this article was written by a well-known group, it has severe methodological problems and may, therefore, confuse the discussion on the topic.
34. Arboix A, Cabeza N, Garcia-Eroles L et al. Relevance of transient ischemic attack to early neurological recovery after nonlacunar ischemic stroke. Cerebrovasc. Dis. 18, 304-311 (2004). (Pubitemid 39664254)
35. Obrenovitch TP. Molecular physiology of preconditioning-induced brain tolerance to ischemic. Physiol. Rev. 88, 211-247 (2008).
36. DeFazio RA, Raval AP, Lin HW et al. GABA synapses mediate neuroprotection after ischemic and e-PKC preconditioning in rat hippocampal slice cultures. J Cereb. Blood Flow Metab. 29, 375-384 (2009).
37. Johnston SC. Ischemic preconditioning from transient ischemic attacks? Data from the Northern California TIA study. Stroke 35, 2680-2682 (2004).
38. Schaller BJ. Influence of age on stroke and preconditioning-induced ischemic tolerance in the brain. Exp. Neurol. 205, 9-19 (2007). • The question of age in stroke is of great interest but, unfortunately, there is a lack of information regarding this topic. The author has collected the current information and provide a good overview in this article.
39. Della Morte D, Abete P, Gallucci F et al. Transient ischemic attack before nonlacunar ischemic stroke in the elderly. J. Stroke Cerebrovasc. Dis. 17, 257-262 (2008).
40. Abete P, Ferrara N, Cacciatore F et al. Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J. Am. Coll. Cardiol. 30, 947-954 (1997). (Pubitemid 27435886)
41. Tani M, Suganuma Y, Hasegawa H et al. Decrease in ischemic tolerance with aging in isolated perfused fischer 344 rat hearts: relation to increases in intracellular Na+ after ischemia. J. Mol. Cell. Cardiol. 29, 3081-3089 (1997). (Pubitemid 27510774)
42. Abete P, Ferrara N, Cioppa A et al. Preconditioning does not prevent postischemic dysfunction in aging heart. J. Am. Coll. Cardiol. 27, 1777-1786 (1996). (Pubitemid 26198034)
43. Stenzel-Poore MP, Stevens SL, Simon RP. Genomics of preconditioning. Stroke 35, 2683-2686 (2004). • Excellent overview of a complex topic by one of the leading groups in the field worldwide.
44. Raval AP, Lin HW, Dave KR et al. Resveratrol and ischemic preconditioning in the brain. Curr. Med. Chem. 15, 1545-1551 (2008).
45. Toth A, Halmosi R, Kovacs K et al. Akt activation induced by an antioxidant compound during ischemia-reperfusion. Free Radic. Biol. Med. 35, 1051-1063 (2003). (Pubitemid 37315698)
46. Wang Q, Peng Y, Chen S et al. Pretreatment with electroacupuncture induces rapid tolerance to focal cerebral ischemia thorugh regulation of endocannabinoid system. Stroke 40, 2157-2164 (2009).